From: Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Characteristic | No. patients (%) |
---|---|
Age | |
< 60 | 8 (40) |
≥ 60 | 12 (60) |
Gender | |
Male | 10 (50) |
Female | 10 (50) |
ECOG performance status | |
0 | 11 (55) |
1 | 9 (45) |
Histology | |
Adenocarcinoma | 7 (35) |
Squamous | 4 (20) |
Renal cell | 3 (15) |
Sarcoma | 2 (10) |
Carcinoid | 2 (10) |
Other | 2 (10) |
Intrathoracic disease | |
Singular | 10 (50) |
Multiple | 10 (50) |
Controlled extrathoracic disease | |
Yes | 13 (65) |
No | 7 (35) |
Extrathoracic organ involvement | |
Visceral | 4 (20) |
Bone | 3 (15) |
None | 13 (65) |
Lung location | |
Right | 13 (65) |
Left | 7 (35) |
Pre-radiotherapy symptoms | |
Shortness of breath | 11 (55) |
Cough | 9 (45) |
Hemoptysis | 3 (15) |
None | 6 (30) |